Lombard Medical, Inc.
EVARFOTCHealthcare● Active
$0.00
$-0.00(-0.00%)
Market Cap$2795
P/E Ratio—
52W High$0.0001
52W Low$0.000001
Lombard Medical, Inc. (EVARF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
EVARF · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2016Report Date: Oct 27, 2016EPS Actual
-$0.37
Est. -$0.26 · -42.3%
Revenue
—
Fiscal Period
Q4 FY2016
FY ends December
Report Date
Oct 27, 2016
After Market Close
▼ Miss EPS
EVARF reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2018 | Aug 24, 2018 | — | — | — | — | — | — |
| ◌ Q2 FY2017 | Apr 18, 2017 | — | — | — | — | — | — |
| ▼ Q4 FY2016 | Oct 27, 2016 | -$0.26 | -$0.37 | -42.3% | — | — | — |
| ▲ Q2 FY2016 | May 11, 2016 | -$0.41 | -$0.38 | +7.3% | — | — | — |
| ▲ Q4 FY2015 | Nov 4, 2015 | -$0.53 | -$0.45 | +15.1% | — | — | — |
| ▲ Q3 FY2015 | Jul 27, 2015 | -$0.55 | -$0.51 | +7.3% | — | — | — |
| ▼ Q2 FY2015 | May 11, 2015 | -$0.58 | -$0.59 | -1.7% | — | — | — |
| ▲ Q4 FY2014 | Oct 29, 2014 | -$0.70 | -$0.52 | +25.7% | — | — | — |
Q3 FY2018
Aug 24, 2018
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2017
Apr 18, 2017
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2016
Oct 27, 2016Miss
EPS Actual
-$0.37
EPS Est.
-$0.26
EPS Surpr.
-42.3%
Revenue
—
Q2 FY2016
May 11, 2016Beat
EPS Actual
-$0.38
EPS Est.
-$0.41
EPS Surpr.
+7.3%
Revenue
—
Q4 FY2015
Nov 4, 2015Beat
EPS Actual
-$0.45
EPS Est.
-$0.53
EPS Surpr.
+15.1%
Revenue
—
Q3 FY2015
Jul 27, 2015Beat
EPS Actual
-$0.51
EPS Est.
-$0.55
EPS Surpr.
+7.3%
Revenue
—
Q2 FY2015
May 11, 2015Miss
EPS Actual
-$0.59
EPS Est.
-$0.58
EPS Surpr.
-1.7%
Revenue
—
Q4 FY2014
Oct 29, 2014Beat
EPS Actual
-$0.52
EPS Est.
-$0.70
EPS Surpr.
+25.7%
Revenue
—
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q4 FY2016 | Oct 27, 2016 | -42.3% | $0.88 | $0.86 | -2.27% |
| ▲ Q2 FY2016 | May 11, 2016 | +7.3% | $1.64 | $1.57 | -4.27% |
| ▲ Q4 FY2015 | Nov 4, 2015 | +15.1% | $3.26 | $3.21 | -1.53% |
| ▲ Q3 FY2015 | Jul 27, 2015 | +7.3% | $3.55 | $3.35 | -5.64% |
| ▼ Q2 FY2015 | May 11, 2015 | -1.7% | $4.68 | $4.62 | -1.39% |
| ▲ Q4 FY2014 | Oct 29, 2014 | +25.7% | $6.99 | $6.60 | -5.58% |
Q4 FY2016-2.27%
Report Date
Oct 27, 2016
EPS Beat/Miss
-42.3%
Price Before
$0.88
Price After
$0.86
Q2 FY2016-4.27%
Report Date
May 11, 2016
EPS Beat/Miss
+7.3%
Price Before
$1.64
Price After
$1.57
Q4 FY2015-1.53%
Report Date
Nov 4, 2015
EPS Beat/Miss
+15.1%
Price Before
$3.26
Price After
$3.21
Q3 FY2015-5.64%
Report Date
Jul 27, 2015
EPS Beat/Miss
+7.3%
Price Before
$3.55
Price After
$3.35
Q2 FY2015-1.39%
Report Date
May 11, 2015
EPS Beat/Miss
-1.7%
Price Before
$4.68
Price After
$4.62
Q4 FY2014-5.58%
Report Date
Oct 29, 2014
EPS Beat/Miss
+25.7%
Price Before
$6.99
Price After
$6.60
Avg Beat Reaction-4.25%
Avg Miss Reaction-1.83%
Beat Rate4 / 6 quarters
Largest Move-5.64% (Q3 FY2015)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: EVARF ends December
Lombard Medical, Inc. (EVARF) most recently reported earnings on October 27, 2016 for Q4 FY2016, posting EPS of $-0.37 — missing the analyst consensus of $-0.26 by -42.3%. The next EVARF earnings date is expected around September 1, 2026.
Each quarter, investors track EVARF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EVARF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EVARF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
EVARF earnings · 5 questionsLombard Medical, Inc.'s next earnings report is expected around September 1, 2026. EVARF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EVARF historically reports after market close (AMC).
EVARF earnings datewhen is EVARF earningsEVARF next earnings datewhen does EVARF report earningsEVARF earnings calendar
▸ Source: FMP · Lombard Medical, Inc. SEC filings · US GAAP · Lombard Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026